Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-24 @ 9:32 PM
NCT ID:
NCT03952832
Brief Title:
Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma
Official Title:
Phase 2 Trial of Leflunomide in Patients With High-Risk Smoldering Multiple Myeloma
Study:
NCT03952832
Protocol Section:
NCT03952832